Navigation Links
Celerion Implements Biometric Fingerprint Technology and Marks Five-Year Anniversary with Verified Clinical Trials
Date:3/13/2017

Celerion was the first early stage contract research organization (CRO) to partner with Verified Clinical Trials to improve participant safety and clinical trial data. Over the last 5 years Celerion performed nearly fifty thousand verifications utilizing the VCT global clinical database registry to identify participants that are currently enrolled in other clinical studies.

Most recently Celerion implemented VCT’s biometric fingerprint technology to augment the accuracy and speed of the verifications performed at our facilities. The use of biometrics adds another layer of protection to ensure dual enrollment in clinical trials does not occur.

Our focus has always been to help our clients get their drugs to market and protect the safety and well-being of our participants. The Verified Clinical Trials database registry enhances our ability to achieve both of those objectives, said Phil Bach, Vice President, Global Clinical Research, Celerion. “Celerion and Verified Clinical Trials share the same vision of applying scientific expertise and advanced technology to ensure the safety of our participants and maintain data integrity leading to successful clinical trial outcomes.”

“Following Celerion’s lead, the majority of Phase I units across North America now utilize the VCT system everyday to protect their clinical trials. Verified Clinical Trials offers the most comprehensive and unique clinical research subject database registry to enhance the quality of both early and late stage studies globally. The system provides a level of safety to the clinical trial process that could not be attained without a solution like Verified Clinical Trials,” said Mitchell Efros, MD FACS, CEO at Verified Clinical Trials.

“By joining forces five years ago, Celerion and VCT led the way in providing a solution that maximizes detection of attempted duplicate enrollment and protocol violations. This combined effort raised awareness and utilization across all phases of clinical research highlighting the need for a research subject database in the clinical trials industry. Working with Celerion’s team over the past five years has been a pleasure” added Kerri Weingard, COO at Verified Clinical Trials.

About Celerion
Translating science into medicine, Celerion is a premier provider of early clinical research and translational clinical pharmacology sciences from their global locations in North America, Europe and Asia.

Celerion conducts First-in-Human, clinical Proof-of-Concept and patient dose response studies, cardiovascular safety and clinical pharmacology research supporting product labeling. With purpose-built clinic and laboratory facilities and highly automated technology, Celerion provides full study services including clinical study conduct, data management and biometrics, PK/PD analysis, bioanalytical services, medical writing, and regulatory and drug development program management. For more information please visit Celerion.

About Verified Clinical Trials
Verified Clinical Trials is a forward thinking company developed by experts active in the clinical research community to proactively improve research subject safety and data quality in clinical research trials. Verified Clinical Trials defines itself as the world’s leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally as well as on a global level. Verified Clinical Trials offers numerous other value added services to the clinical research site, CRO, and Pharmaceutical Sponsor, that prove invaluable with regards to financial and legal issues and liabilities. For more information, visit http://www.verifiedclinicaltrials.com.

Read the full story at http://www.prweb.com/releases/CelerionVCT/duplicateenrollment/prweb14142364.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Infinata Implements “Clear Quality” Initiative to Optimize Reliability and Usability of Data, Reports and Analysis for Biopharma and Wealth Management Solutions
2. Sarah Cannon Research Institute Implements Virtify CTRR
3. Life Science Equipment Manufacturer and Distributor Implements Accounts Receivable Collections Software for Sage 100 ERP
4. Kymab Implements Genedata Biologics for High-throughput Antibody Discovery
5. Lajollacooks4u Implements Popular New Team Building Format
6. Sigma Blood Systems Implements PERFEQTA Software With Central Jersey Blood Center
7. Jupiter Medical Center Implements Revolutionary Watson for Oncology to Help Oncologists Make Data-Driven Cancer Treatment Decisions
8. Barska Biometric Fingerprint Scanning Safes Now Available At B&H Photo Video
9. Global Biometric Systems Market Forecast Report - Opportunities to 2018
10. Cartes 2013: DERMALOG Presents World Firsts in Biometrics
11. Biometrics market in South East Asia and ANZ to grow at a CAGR of 15.82 percent over the period 2013-2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/10/2020)... ... January 09, 2020 , ... ... announced its inaugural GenScript Biotech Global Forum on Jan. 14 in San Francisco, ... "Cell and Gene Therapy and the Booming China Market," will feature gene and ...
(Date:1/7/2020)... ... , ... Vuja De Sciences (“Vuja De”), a biotechnology startup dedicated to developing ... Chand Khanna, DVM, PhD, DACVIM (Onc), and Dr. Lee Helman, MD, to its Board ... to welcome Chand and Lee as new directors. They will be of great help ...
(Date:12/31/2019)... ... December 31, 2019 , ... Vici Health ... development lab in Maryland. Emphasis will be in expanding capabilities in both ... Health Sciences will be well positioned to meet the growing demand for its ...
(Date:12/27/2019)... , ... December 27, 2019 , ... ... studies for its 505(b)(2) product pipeline that offers patients and healthcare ... The products concepts were identified in collaboration with doctors and managed care professionals ...
Breaking Biology Technology:
(Date:12/4/2019)... MELVILLE, N.Y. (PRWEB) , ... December 04, 2019 ... ... growing aesthetics companies today, has launched Subnovii Advanced Plasma Technology for ... their breakthrough portfolio, Subnovii is the only plasma to employ LF technology – ...
(Date:11/27/2019)... ... November 27, 2019 , ... ... device, equipped with surface electromyography (sEMG) sensors that measure and display muscle activity ... the specific muscles being targeted for treatment. Both patient and therapist can see ...
(Date:11/19/2019)... (PRWEB) , ... November 19, 2019 , ... The inaugural ... Times Square in New York City. The one-day event will be chaired by Dr ... of leaders in the space. , “We are witnessing significant innovation in cell ...
Breaking Biology News(10 mins):